JNJ-49095397

CAS No. 1220626-82-3

JNJ-49095397( RV568 | RV-568 | JNJ49095397 )

Catalog No. M10833 CAS No. 1220626-82-3

JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 202 In Stock
10MG 330 In Stock
25MG 660 In Stock
50MG 1014 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JNJ-49095397
  • Note
    Research use only, not for human use.
  • Brief Description
    JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively.
  • Description
    JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively; shows potent anti-inflammatory effects in monocytes and macrophages, demonstrates synergistic interaction in poly I:C-stimulated BEAS-2B cells and in the cigarette smoke model combined with corticosteroid.COPD Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Nonfasted Balb/c mice, LPS-induced neutrophil accumulation model Dosage:1, 4 and 20 μg/mouse Administration:Intratracheal administration, 2, 8 or 12 h prior to LPS inhalation Result:Prevented the accumulation of neutrophils in the BAL fluid. Significantly inhibited neutrophil accumulation when administered up to 8 h prior to LPS inhalation.
  • Synonyms
    RV568 | RV-568 | JNJ49095397
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    Inflammation/Immunology
  • Indication
    COPD

Chemical Information

  • CAS Number
    1220626-82-3
  • Formula Weight
    592.7
  • Molecular Formula
    C34H36N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (168.72 mM)
  • SMILES
    CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCC5=CC(=NC=C5)NC(=O)COC
  • Chemical Name
    N-(4-((4-(3-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)-naphthalen-1-yloxy)methyl)yridin-2-yl)-2-methoxyacetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Onions ST, et al. J Med Chem. 2016 Mar 10;59(5):1727-46. 2. Charron CE, et al. Eur Respir J. 2017 Oct 26;50(4). pii: 1700188.
molnova catalog
related products
  • PH797804

    PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM in a cell-free assay; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.

  • Cot inhibitor-1

    Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM.

  • PF-03715455

    PF-03715455 is a highly potent and selective inhibitor for p38α MAPK with IC50 of 1.6 nM.